跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Prostaron - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Prostaron
Approved
STANDARD
Prostaron
Remedica Ltd. (Building 10-Antineoplastic & Immunomodulating Products)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8b6dbfefbf65514d
Company
Remedica Ltd. (Building 10-Antineoplastic & Immunomodulating Products)
Type
Standard
Approval Details
Approval Id
8b6dbfefbf65514d
Drug Approval Philippines Name
Prostaron
Product Name
Prostaron
Registration Number
DRP-16397
Brand Name
Prostaron
Generic Name
Abiraterone acetate
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Remedica Ltd. (Building 10-Antineoplastic & Immunomodulating Products)
Issuance Date
27 February 2025
Expiry Date
27 February 2030
Pharmacologic Category
Endocrine Therapy
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8b6dbfefbf65514d
Type
Standard
Back to Philippines FDA Approvals